Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 31 results.
User Information
Export Records
  1. 1.   Are We Making PROGRESS in Preventing Graft-versus-Host Disease and Improving Clinical Outcomes? Impact of BMT CTN 1301 Study Results on Clinical Practice
  2. Hamilton, Betty K; Cutler, Corey; Divine, Clint; Juckett, Mark; LeMaistre, Charles; Stewart, Susan; Wilder, Jennifer; Horowitz, Mary; Khera, Nandita; Burns, Linda J
  3. Transplantation and Cellular Therapy. 2022, May 09;
  1. 2.   Failure to Prevent Severe Graft-Versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide in Chronic Granulomatous Disease
  2. Parta,Mark; Hilligoss, Dianne; Kelly, Corin; Kwatemaa, Nana; Theobald, Narda; Zerbe, Christa S; Holland, Steven M; Malech, Harry L; Kang, Elizabeth M
  3. Journal of clinical immunology. 2020, Apr 20;
  1. 3.   The MHC in the era of next-generation sequencing: Implications for bridging structure with function
  2. Petersdorf, Effie W.; Ohuigin,Colm
  3. HUMAN IMMUNOLOGY. 2019, Jan; 80(1): 67-78.
  1. 4.   Hydrodynamic Delivery of Human IL-15 cDNA Increases Murine Natural Killer Cell Recovery after Syngeneic Bone Marrow Transplantation
  2. Barao, I.; Alvarez, M.; Redelman, D.; Weiss, J. M.; Ortaldo, J. R.; Wiltrout, R. H.; Murphy, W. J.
  3. Biology of Blood and Marrow Transplantation. 2011, Dec; 17(12): 1754-1764.
  1. 5.   Successful allogeneic hematopoietic stem cell transplantation for GATA2 deficiency
  2. Cuellar-Rodriguez, J.; Gea-Banacloche, J.; Freeman, A. F.; Hsu, A. P.; Zerbe, C. S.; Calvo, K. R.; Wilder, J.; Kurlander, R.; Olivier, K. N.; Holland, S. M.; Hickstein, D. D.
  3. Blood. 2011, Sep; 118(13): 3715-3720.
  1. 6.   Damaged Intestinal Epithelial Integrity Linked to Microbial Translocation in Pathogenic Simian Immunodeficiency Virus Infections
  2. Estes, J. D.; Harris, L. D.; Klatt, N. R.; Tabb, B.; Pittaluga, S.; Paiardini, M.; Barclay, G. R.; Smedley, J.; Pung, R.; Oliveira, K. M.; Hirsch, V. M.; Silvestri, G.; Douek, D. C.; Miller, C. J.; Haase, A. T.; Lifson, J.; Brenchley, J. M.
  3. Plos Pathogens. 2010, Aug; 6(8): 15.
  1. 7.   Bone marrow deficient in IFN-gamma signaling selectively reverses GVHD-associated immunosuppression and enhances a tumor-specific GVT effect
  2. Capitini, C. M.; Herby, S.; Milliron, M.; Anver, M. R.; Mackall, C. L.; Fry, T. J.
  3. Blood. 2009 113(20): 5002-5009.
  1. 8.   Successful granulocyte-colony stimulating factor treatment of Crohn's disease is associated with the appearance of circulating interleukin-10-producing T cells and increased lamina propria plasmacytoid dendritic cells
  2. Mannon, P. J.; Leon, F.; Fuss, I. J.; Walter, B. A.; Begnami, M.; Quezado, M.; Yang, Z.; Yi, C.; Groden, C.; Friend, J.; Hornung, R. L.; Brown, M.; Gurprasad, S.; Kelsall, B.; Strober, W.
  3. Clinical and Experimental Immunology. 2009 155(3): 447-456.
  1. 9.   Differential effects of donor T-cell cytokines on outcome with continuous bortezomib administration after allogeneic bone marrow transplantation
  2. Sun, K.; Li, M. H.; Sayers, T. J.; Welniak, L. A.; Murphy, W. J.
  3. Blood. 2008 112(4): 1522-1529.
  1. 10.   Peyer patches are not required for acute graft-versus-host disease after myeloablative conditioning and murine allogeneic bone marrow transplantation
  2. Welniak, L. A.; Kuprash, D. V.; Tumanov, A. V.; Panoskaltsis-Mortari, A.; Blazar, B. R.; Sun, K.; Nedospasov, S. A.; Murphy, W. J.
  3. Blood. 2006, JAN 1; 107(1): 410-412.
  1. 11.   Differential effects of proteasome inhibition by bortezomib on murine acute graft-versus-host disease (GVHD): delayed administration of bortezomib results in increased GVHD-dependent gastrointestinal toxicity
  2. Sun, K.; Wilkins, D. E. C.; Anver, M. R.; Sayers, T. J.; Panoskaltsis-Mortari, A.; Blazar, B. R.; Weiniak, L. A.; Murphy, W. J.
  3. Blood. 2005, NOV 1; 106(9): 3293-3299.
  1. 12.   Triptolide, a constituent of immunosuppressive Chinese herbal medicine, is a potent suppressor of dendritic-cell maturation and trafficking
  2. Chen, X.; Murakami, T.; Oppenheim, J. J.; Howard, O. M. Z.
  3. Blood. 2005, OCT 1; 106(7): 2409-2416.
  1. 13.   Limiting dilution analysis of interleukin-2 producing helper T-cell frequencies as a tool in allogeneic hematopoietic cell transplantation
  2. Petersen, S. L.; Sidorov, I. A.; Russell, C. A.; Dickmeiss, E.; Vindelov, L. L.
  3. Transplantation. 2005, SEP 15; 80(5): 573-581.
  1. 14.   Differential response of murine CD4(+)CD25(+) and CD4(+)CD25(-) T cells to dexamethasone-induced cell death
  2. Chen, X.; Murakami, T.; Oppenheim, J. J.; Howard, D. M. Z.
  3. European Journal of Immunology. 2004 34(3): 859-869.
  1. 15.   Host conditioning is a primary determinant in modulating the effect of IL-7 on murine graft-versus-host disease
  2. Gendelman, M.; Hecht, T.; Logan, B.; Vodanovic-Jankovic, S.; Komorowski, R.; Drobyski, W. R.
  3. Journal of Immunology. 2004 172(5): 3328-3336.
  1. 16.   Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib
  2. Sun, K.; Welniak, L. A.; Panoskaltsis-Mortari, A.; O'Shaughnessy, M. J.; Liu, H. Y.; Barao, I.; Riordan, W.; Sitcheran, R.; Wysocki, C.; Serody, J. S.; Blazar, B. R.; Sayers, T. J.; Murphy, W. J.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2004 101(21): 8120-8125.
  1. 17.   IL-10 and TGF-beta induce alloreactive CD4(+)CD25(-) T cells to acquire regulatory cell function
  2. Chen, Z. M.; O'Shaughnessy, M. J.; Gramaglia, I.; Panoskaltsis-Mortari, A.; Murphy, W. J.; Narula, S.; Roncarolo, M. G.; Blazar, B. R.
  3. Blood. 2003 101(12): 5076-5083.
  1. 18.   PS-341 administration inhibits acute graft-versus-host disease and preserves graft-versus-tumor after allogeneic BMT in advanced tumor-bearing mice
  2. Sun, K.; Welniak, L. A.; Wilkins, D.; Panoskaltsis-Mortari, A.; Blazar, B. R.; Sayers, T. J.; Murphy, W. J.
  3. Blood. 2003 102(11, Part 1): 192A-192A.
  1. 19.   Antibodies to CD40 induce a lethal cytokine cascade after syngeneic bone marrow transplantation
  2. Hixon, J. A.; Blazar, B. R.; Anver, M. R.; Wiltrout, R. H.; Murphy, W. J.
  3. Biology of Blood and Marrow Transplantation. 2001 7(3): 136-143.
  1. 20.   Renal transplant patients show variations in their self- reactive repertoires: a serial study
  2. Portugal, K.; Dozmorov, I.; Sidorov, I.; Marrero, I.; Fonseca, J. A.; Spadafora-Ferreira, M.; Kalil, J.; Coelho, V.
  3. International Immunology. 2001 13(6): 747-755.
  1. 21.   Calcium signaling inhibits interleukin-12 production and activates CD83(+) dendritic cells that induce Th2 cell development
  2. Faries, M. B.; Bedrosian, I.; Xu, S. W.; Koski, G.; Roros, J. G.; Moise, M. A.; Nguyen, H. Q.; Engels, F. H. C.; Cohen, P. A.; Czerniecki, B. J.
  3. Blood. 2001 98(8): 2489-2497.
  1. 22.   Immunobiology of natural killer cells and bone marrow transplantation: merging of basic and preclinical studies
  2. Murphy, W. J.; Koh, C. Y.; Raziuddin, A.; Bennett, M.; Longo, D. L.
  3. Immunological Reviews. 2001 181: 279-289.
  1. 23.   Unlocking the secrets of cytotoxic granule proteins
  2. Smyth, M. J.; Kelly, J. M.; Sutton, V. R.; Davis, J. E.; Browne, K. A.; Sayers, T. J.; Trapani, J. A.
  3. Journal of Leukocyte Biology. 2001 70(1): 18-29.
  1. 24.   Induction of monocyte- and T-cell-attracting chemokines in the lung during the generation of idiopathic pneumonia syndrome following allogeneic murine bone marrow transplantation
  2. Panoskaltsis-Mortari, A.; Strieter, R. M.; Hermanson, J. R.; Fegeding, K. V.; Murphy, W. J.; Farrell, C. L.; Lacey, D. L.; Blazar, B. R.
  3. Blood. 2000 96(3): 834-839.
  1. 25.   Adoptive cellular immunotherapy: NK cells and bone marrow transplantation
  2. Koh, C. Y.; Welniak, L. A.; Murphy, W. J.
  3. Histology and Histopathology. 2000 15(4): 1201-1210.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel